Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Randomised, Double-Blind, Placebo-Controlled, Multi-Centre Study to Investigate the Impact of Diamyd® on the Progression of Diabetes in Patients Newly Diagnosed With Type 1 Diabetes Mellitus

NCT00435981 is registered in ClinicalTrials.gov with Diamyd Therapeutics AB as lead sponsor.

NCT NCT00435981
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00435981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Randomised, Double-Blind, Placebo-Controlled, Multi-Centre Study to Investigate the Impact of Diamyd® on the Progression of Diabetes in Patients Newly Diagnosed With Type 1 Diabetes Mellitus
Lead sponsor
Diamyd Therapeutics AB
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2005
Completion date
December 31, 2007
Enrollment
70
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes